Ocera Therapeutics, Inc. Financing Cash Flow
Ocera Therapeutics, Inc. reported Financing Cash Flow of $2.15 million for the 9-month period ending 2017-09-30, per its 10-Q filed 2017-11-14.
Discontinued › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2017-11-14
- Ocera Therapeutics, Inc. net cash provided by (used in) financing activities for the quarter ending 2017-09-30 was -$935.00K, a 130.87% decline year-over-year.
- Ocera Therapeutics, Inc. net cash provided by (used in) financing activities for the quarter ending 2017-06-30 was -$164.00K, a 113.27% decline year-over-year.
- Ocera Therapeutics, Inc. net cash provided by (used in) financing activities for the quarter ending 2017-03-31 was $3.25M, a 84.86% increase year-over-year.
- Ocera Therapeutics, Inc. net cash provided by (used in) financing activities for the quarter ending 2016-09-30 was $3.03M, a 74.36% decline year-over-year.
- Ocera Therapeutics, Inc. net cash provided by (used in) financing activities for fiscal 2012 was -$1.89M, a 103.75% decline from fiscal 2011.
- Ocera Therapeutics, Inc. net cash provided by (used in) financing activities for fiscal 2011 was $50.45M, a 539.45% increase from fiscal 2010.
- Ocera Therapeutics, Inc. net cash provided by (used in) financing activities for fiscal 2010 was $7.89M, a 11.19% decline from fiscal 2009.
- Ocera Therapeutics, Inc. net cash provided by (used in) financing activities for fiscal 2009 was $8.88M.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 9 month as first filed | Net Cash Provided by (Used in) Financing Activities 12 month | Net Cash Provided by (Used in) Financing Activities 105 month |
|---|---|---|---|---|---|---|
| 2017-09-30 | -$935.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-14 | -$1.10M derived: sum of 2 quarters · filed 2017-11-14 | $2.15M 10-Q · filed 2017-11-14 | |||
| 2017-06-30 | -$164.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-01 | $3.08M 10-Q · filed 2017-08-01 | ||||
| 2017-03-31 | $3.25M 10-Q · filed 2017-05-09 | |||||
| 2016-09-30 | $3.03M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-14 | $4.26M derived: sum of 2 quarters · filed 2017-11-14 | $6.02M 10-Q · filed 2017-11-14 | |||
| 2016-06-30 | $1.24M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-01 | $2.99M 10-Q · filed 2017-08-01 | ||||
| 2016-03-31 | $1.76M 10-Q · filed 2017-05-09 | |||||
| 2015-09-30 | $11.81M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-02 | $12.23M derived: sum of 2 quarters · filed 2016-11-02 | $12.23M 10-Q · filed 2016-11-02 | |||
| 2015-06-30 | $413.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | $413.00K 10-Q · filed 2016-08-04 | ||||
| 2015-03-31 | $0.00 10-Q · filed 2016-05-03 | |||||
| 2013-09-30 | $20.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-14 | $20.00M derived: sum of 2 quarters · filed 2013-11-14 | $20.00M 10-Q · filed 2013-11-14 | $16.59M derived: sum of 4 quarters · filed 2013-11-14 | $84.77M 10-Q · filed 2013-11-14 | |
| 2013-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-14 | $0.00 10-Q · filed 2013-08-14 | -$3.41M derived: sum of 3 quarters · filed 2013-08-14 | -$10.43M derived: sum of 4 quarters · filed 2013-11-14 | ||
| 2013-03-31 | $0.00 10-Q · filed 2013-05-14 | -$3.41M derived: sum of 2 quarters · filed 2013-05-14 | -$10.43M derived: sum of 3 quarters · filed 2013-11-14 | -$10.43M derived: sum of 4 quarters · filed 2013-11-14 | ||
| 2012-12-31 | -$3.41M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-28 | -$10.43M derived: sum of 2 quarters · filed 2013-11-14 | -$10.43M derived: sum of 3 quarters · filed 2013-11-14 | -$1.89M 10-K · filed 2013-03-28 | ||
| 2012-09-30 | -$7.03M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-14 | -$7.03M derived: sum of 2 quarters · filed 2013-11-14 | $1.51M 10-Q · filed 2013-11-14 | $19.14M 10-Q · filed 2012-11-09 | $415.00K derived: sum of 4 quarters · filed 2013-11-14 | |
| 2012-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-14 | $8.54M 10-Q · filed 2013-08-14 | $7.44M derived: sum of 3 quarters · filed 2013-08-14 | $6.48M derived: sum of 4 quarters · filed 2013-08-14 | ||
| 2012-03-31 | $8.54M 10-Q · filed 2013-05-14 | $7.44M derived: sum of 2 quarters · filed 2013-05-14 | $6.48M derived: sum of 3 quarters · filed 2013-05-14 | $59.47M derived: sum of 4 quarters · filed 2013-05-14 | ||
| 2011-12-31 | -$1.10M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-28 | -$2.05M derived: sum of 2 quarters · filed 2013-03-28 | $50.93M derived: sum of 3 quarters · filed 2013-03-28 | $50.45M 10-K · filed 2013-03-28 | ||
| 2011-09-30 | -$956.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09 | $52.03M derived: sum of 2 quarters · filed 2012-11-09 | $51.54M 10-Q · filed 2012-11-09 | $59.84M derived: sum of 4 quarters · filed 2013-03-28 | ||
| 2011-06-30 | $52.98M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-10 | $52.50M 10-Q · filed 2012-08-10 | $60.80M derived: sum of 3 quarters · filed 2013-03-28 | $59.98M derived: sum of 4 quarters · filed 2013-03-28 | ||
| 2011-03-31 | -$483.00K 10-Q · filed 2012-05-11 | $7.81M derived: sum of 2 quarters · filed 2013-03-28 | $7.00M derived: sum of 3 quarters · filed 2013-03-28 | |||
| 2010-12-31 | $8.30M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-28 | $7.48M derived: sum of 2 quarters · filed 2013-03-28 | $7.89M 10-K · filed 2013-03-28 | |||
| 2010-09-30 | -$814.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-10 | -$408.00K 10-Q · filed 2011-11-10 | ||||
| 2010-06-30 | $406.00K 10-Q · filed 2011-08-11 | |||||
| 2009-12-31 | $8.88M 10-K · filed 2012-02-29 |